drugset / Trial / NCT04130438

Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging

NCT04130438

Phase 2 Terminated 5 enrolled Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

The proposed clinical trial is relevant to public health because it is expected to expand the differential diagnosis and provide an evidence--based therapy for the large population of patients with angina in the absence of obstructive CAD who currently remain undiagnosed and untreated. It, therefore, upholds an important part of the mission of the The National Heart, Lung, and Blood Institute (NHLBI), which is to promote the treatment of heart disease and enhance the health of all individuals so that they can live longer and more fulfilling lives.

Timeline

Start
2020-10-15
Primary completion
2022-03-11
Completion
2024-10-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diltiazem Small molecule 120 mg
Comparator Nebivolol Other / unclassified 2.5 mg Oral